Marshall C Peterman

Title: Marshall C. Peterman: Innovator in Pharmaceutical Compounds

Introduction

Marshall C. Peterman is a notable inventor based in Oceanside, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific proteins involved in various diseases. With a total of 2 patents to his name, Peterman's work is paving the way for new treatment options.

Latest Patents

Peterman's latest patents focus on dual acting FKBP12 and FKBP52 inhibitors. These patents provide novel compounds of Formulas (I) and (II), along with their pharmaceutically acceptable salts and compositions. These compounds are particularly useful as dual FKBP12/FKBP inhibitors. Furthermore, the pharmaceutical compositions comprising these novel compounds are aimed at treating Parkinson's disease, showcasing the potential impact of his work on neurological health.

Career Highlights

Marshall C. Peterman is associated with Plex Pharmaceuticals, Inc., where he continues to innovate and develop new pharmaceutical solutions. His expertise in the field has led to advancements that could significantly improve treatment methodologies for various conditions.

Collaborations

Peterman has collaborated with notable colleagues, including Surya Kanta De and Sridhar G. Prasad. These partnerships enhance the research and development efforts at Plex Pharmaceuticals, Inc., contributing to a collaborative environment that fosters innovation.

Conclusion

Marshall C. Peterman's contributions to pharmaceutical inventions, particularly in the area of FKBP inhibitors, highlight his role as a key innovator in the industry. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in the treatment of Parkinson's disease.